These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24096633)

  • 21. [Not Available].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):877-886. PubMed ID: 26115869
    [No Abstract]   [Full Text] [Related]  

  • 22. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.
    Poveda E; Seclén E; González Mdel M; García F; Chueca N; Aguilera A; Rodríguez JJ; González-Lahoz J; Soriano V
    J Antimicrob Chemother; 2009 May; 63(5):1006-10. PubMed ID: 19261623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating the date of origin of an HIV-1 circulating recombinant form.
    Tee KK; Pybus OG; Parker J; Ng KP; Kamarulzaman A; Takebe Y
    Virology; 2009 Apr; 387(1):229-34. PubMed ID: 19272628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes.
    Delgado E; Fernández-García A; Vega Y; Cuevas T; Pinilla M; García V; Sánchez M; González M; Sánchez AM; Thomson MM; Pérez-Álvarez L
    J Antimicrob Chemother; 2012 Jan; 67(1):25-31. PubMed ID: 22010208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS).
    Yebra G; de Mulder M; Martín L; Pérez-Cachafeiro S; Rodríguez C; Labarga P; García F; Tural C; Jaén A; Navarro G; Holguín A;
    Antiviral Res; 2011 Jan; 89(1):19-25. PubMed ID: 21070813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain.
    Fernández-García A; Pérez-Alvarez L; Cuevas MT; Delgado E; Muñoz-Nieto M; Cilla G; Iribarren JA; Pinilla M; Ocampo A; Miralles C; Pérez-Castro S; González-Galeano M; de Castro RO; Trigo M; García V; Sánchez AM; Thomson MM
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):827-32. PubMed ID: 20618102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombination and drug resistance in HIV: population dynamics and stochasticity.
    Kouyos RD; Fouchet D; Bonhoeffer S
    Epidemics; 2009 Mar; 1(1):58-69. PubMed ID: 21352751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms.
    Holguín A; López M; Soriano V
    J Clin Microbiol; 2008 Dec; 46(12):3896-9. PubMed ID: 18842935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current world literature.
    Curr Opin HIV AIDS; 2010 Jul; 5(4):350-5. PubMed ID: 20539087
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV virology for clinical trials.
    Shafer RW; Merigan TC
    AIDS; 1995; 9 Suppl A():S193-202. PubMed ID: 8819586
    [No Abstract]   [Full Text] [Related]  

  • 31. Single genotypes underestimate the prevalence of antiretroviral resistance in patients with perinatally acquired HIV.
    Contreras GA; Delbianco G; Bell CS; Kleinosky MT; Murphy JR; Heresi GP
    J Infect; 2012 Jan; 64(1):125-6. PubMed ID: 22079500
    [No Abstract]   [Full Text] [Related]  

  • 32. The performance of the VIKIA(®) HIV1/2 rapid test-evaluation of the reliability and sensitivity.
    Gomes C; Azevedo-Pereira JM
    J Virol Methods; 2011 May; 173(2):353-6. PubMed ID: 21419168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular diversity of HIV in Albania.
    Ciccozzi M; Gori C; Boros S; Ruiz-Alvarez MJ; Harxhi A; Dervishi M; Qyra S; Schinaia N; D'Arrigo R; Ceccherini-Silberstein F; Bino S; Perno CF; Rezza G
    J Infect Dis; 2005 Aug; 192(3):475-9. PubMed ID: 15995961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
    J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitating viral recombination.
    Griffiths PD
    Rev Med Virol; 2002; 12(6):335-6. PubMed ID: 12410526
    [No Abstract]   [Full Text] [Related]  

  • 36. [New guideline for HIV classification and nomenclature: issues related to the origins of HIVs and biological correlates of HIV-1 subtypes].
    Takebe Y
    Uirusu; 2000 Dec; 50(2):123-38. PubMed ID: 11276804
    [No Abstract]   [Full Text] [Related]  

  • 37. Using HIV resistance tests in clinical practice.
    Taylor S; Jayasuriya A; Smit E
    J Antimicrob Chemother; 2009 Aug; 64(2):218-22. PubMed ID: 19535382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV drug resistance: overview of clinical data.
    Miller V
    J HIV Ther; 2001 Aug; 6(3):68-71. PubMed ID: 11555740
    [No Abstract]   [Full Text] [Related]  

  • 39. Grim news for vaccine.
    AIDS Patient Care STDS; 2002 Oct; 16(10):513-4. PubMed ID: 12442739
    [No Abstract]   [Full Text] [Related]  

  • 40. Recently agreed changes to the International Code of Virus Classification and Nomenclature.
    Adams MJ; Lefkowitz EJ; King AM; Carstens EB
    Arch Virol; 2013 Dec; 158(12):2633-9. PubMed ID: 23836393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.